Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome
scientific article published on 14 May 2012
Author/s
author: Hagop Kantarjian, Stefan Faderl, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Guillermo Garcia-Manero, Jorge Eduardo Cortes, Tapan M Kadia, Marina Konopleva, Mark J Brandt, Deborah A McCue, Francesco P Tambaro
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.